[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1028718T3 - Formulering med opretholdt frigivelse indeholdende venlafaxin - Google Patents

Formulering med opretholdt frigivelse indeholdende venlafaxin

Info

Publication number
DK1028718T3
DK1028718T3 DK98956487T DK98956487T DK1028718T3 DK 1028718 T3 DK1028718 T3 DK 1028718T3 DK 98956487 T DK98956487 T DK 98956487T DK 98956487 T DK98956487 T DK 98956487T DK 1028718 T3 DK1028718 T3 DK 1028718T3
Authority
DK
Denmark
Prior art keywords
sustained release
release formulation
formulation containing
containing venlafaxine
venlafaxine
Prior art date
Application number
DK98956487T
Other languages
English (en)
Inventor
Deborah Marie Sherman
John Clifton Clark
John Ulrick Lamer
Stephen Andrew White
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1028718(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1028718T3 publication Critical patent/DK1028718T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98956487T 1997-11-05 1998-11-03 Formulering med opretholdt frigivelse indeholdende venlafaxin DK1028718T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05
PCT/US1998/023338 WO1999022724A2 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Publications (1)

Publication Number Publication Date
DK1028718T3 true DK1028718T3 (da) 2003-07-28

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956487T DK1028718T3 (da) 1997-11-05 1998-11-03 Formulering med opretholdt frigivelse indeholdende venlafaxin

Country Status (39)

Country Link
EP (1) EP1028718B1 (da)
JP (1) JP2001521892A (da)
KR (1) KR20010031797A (da)
CN (1) CN1278165A (da)
AR (1) AR014012A1 (da)
AT (1) ATE237320T1 (da)
AU (1) AU747978B2 (da)
BG (1) BG104397A (da)
BR (1) BR9813179A (da)
CA (1) CA2305242A1 (da)
CL (1) CL2004001705A1 (da)
CO (1) CO5011060A1 (da)
CZ (1) CZ20001659A3 (da)
DE (1) DE69813602T2 (da)
DK (1) DK1028718T3 (da)
EA (1) EA200000487A1 (da)
EE (1) EE04577B1 (da)
ES (1) ES2196620T3 (da)
GE (1) GEP20043198B (da)
HK (1) HK1029056A1 (da)
HR (1) HRP20000213B1 (da)
HU (1) HU225238B1 (da)
ID (1) ID26317A (da)
IL (1) IL135457A0 (da)
MA (1) MA24691A1 (da)
NO (1) NO20002126L (da)
NZ (1) NZ504460A (da)
PA (1) PA8462501A1 (da)
PE (1) PE128699A1 (da)
PL (1) PL341141A1 (da)
PT (1) PT1028718E (da)
SK (1) SK6472000A3 (da)
SV (1) SV1998000131A (da)
TR (1) TR200001232T2 (da)
TW (1) TW555568B (da)
UA (1) UA77145C2 (da)
UY (2) UY25234A1 (da)
WO (1) WO1999022724A2 (da)
ZA (1) ZA9810081B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2305606T3 (es) * 1999-04-06 2008-11-01 Sepracor Inc. Succinato de o-desmetilvenlafaxina.
SK286865B6 (sk) * 1999-05-20 2009-06-05 Elan Pharma International Limited Multičasticový farmaceutický prostriedok s riadeným uvoľňovaním selektívneho inhibítora spätného príjmu serotonínu a jeho použitie
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
KR20050044673A (ko) * 2001-12-05 2005-05-12 와이어쓰 벤라팍신 하이드로클로라이드의 신규한 결정 다형체 및이의 제조방법
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
EP1474123A1 (en) * 2002-01-03 2004-11-10 LEK Pharmaceuticals D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003082806A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Venlafaxine base
AR039164A1 (es) 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
WO2003082804A1 (en) 2002-03-28 2003-10-09 Synthon B.V. Venlafaxine besylate
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
SI1502587T1 (sl) * 2003-07-30 2007-02-28 Pharmathen Sa Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
KR20070000439A (ko) 2004-02-04 2007-01-02 알렘빅 리미티드 벤라팍신 히드로클로라이드의 방출연장형 코팅 미니정제
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
TW555568B (en) 2003-10-01
PA8462501A1 (es) 2000-05-24
JP2001521892A (ja) 2001-11-13
HK1029056A1 (en) 2001-03-23
PT1028718E (pt) 2003-07-31
HUP0004287A2 (hu) 2002-04-29
EE200000212A (et) 2001-04-16
GEP20043198B (en) 2004-03-25
SK6472000A3 (en) 2000-11-07
HUP0004287A3 (en) 2002-05-28
BG104397A (en) 2001-02-28
CA2305242A1 (en) 1999-05-14
UY25234A1 (es) 2000-12-29
AR014012A1 (es) 2001-01-31
MA24691A1 (fr) 1999-07-01
ZA9810081B (en) 2000-05-04
DE69813602D1 (de) 2003-05-22
IL135457A0 (en) 2001-05-20
NO20002126D0 (no) 2000-04-26
SV1998000131A (es) 1999-11-18
TR200001232T2 (tr) 2000-12-21
KR20010031797A (ko) 2001-04-16
BR9813179A (pt) 2000-08-22
ID26317A (id) 2000-12-14
ATE237320T1 (de) 2003-05-15
AU1300399A (en) 1999-05-24
PL341141A1 (en) 2001-03-26
HRP20000213B1 (en) 2004-04-30
WO1999022724A2 (en) 1999-05-14
EE04577B1 (et) 2006-02-15
CO5011060A1 (es) 2001-02-28
EP1028718B1 (en) 2003-04-16
EP1028718A2 (en) 2000-08-23
ES2196620T3 (es) 2003-12-16
UY25692A1 (es) 2000-03-31
NZ504460A (en) 2003-01-31
HRP20000213A2 (en) 2000-12-31
WO1999022724A3 (en) 1999-07-22
PE128699A1 (es) 2000-01-06
HU225238B1 (en) 2006-08-28
CL2004001705A1 (es) 2005-06-03
AU747978B2 (en) 2002-05-30
NO20002126L (no) 2000-05-04
CZ20001659A3 (cs) 2001-10-17
DE69813602T2 (de) 2003-11-06
EA200000487A1 (ru) 2000-10-30
UA77145C2 (en) 2006-11-15
CN1278165A (zh) 2000-12-27

Similar Documents

Publication Publication Date Title
DK1028718T3 (da) Formulering med opretholdt frigivelse indeholdende venlafaxin
NO20012636L (no) Kontrollert frigivelsesformulering som omfatter GNRH-II
IL120382A0 (en) Extended release formulation of venlafaxine hydrochloride
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
IS5393A (is) Ný froðumyndandi lyfjablanda
DK0973527T3 (da) Clarithromycinformuleringer med forlænget frigivelse
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
PT1023033E (pt) Composicao para penteado remodelavel
ID22939A (id) Formulasi-formulasi farmasi yang mengandung vorikonozal
DE69813125D1 (de) Zapfenlager
ATE227074T1 (de) Mikrokapsel-formulierungen
DK0880892T5 (da) Midler med reguleret frigivelse
DE69816760D1 (de) Trennfolie
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
ATE232683T1 (de) Mikrokapsel-formulierungen
DE69800779D1 (de) Photopolymerisierbare Zusammensetzung
DE59409547D1 (de) Trennmittel
NO993944L (no) Utlösermekanisme
ZA9810710B (en) Sustained release formulations comprising alpha-glucosidase-inhibitors
DE69814051D1 (de) Trennmittel
IS5260A (is) Uppleystar sertralín samsetningar
GB9725061D0 (en) Revitalisation formulation
ATE268607T1 (de) Allergenformulierung
DE69402897D1 (de) Trennmittelzusammensetzung
SI1028718T1 (en) Extended release formulation containing venlafaxin